Zobrazeno 1 - 8
of 8
pro vyhledávání: '"33"'
Autor:
Varun Dhir, Shefali Khanna Sharma, Jasmina Ahluwalia, Ashwani Sood, Atit A Gawalkar, Aman Sharma, Ajay Bahl
Publikováno v:
Lupus. 29:1503-1508
Background Small case-series have reported overt myocardial dysfunction to be associated with positive antiphospholipid antibodies in patients of systemic lupus erythematosus (SLE). However, there is no case-control study that has examined this assoc
Publikováno v:
Langkilde, H, Voss, A, Heegaard, N & Laustrup, H 2017, ' Autoantibodies persist in relatives to systemic lupus erythematosus patients during 12 years follow-up ', Lupus, vol. 26, no. 7, pp. 723-728 . https://doi.org/10.1177/0961203316676378
Background Systemic lupus erythematosus (SLE) is an autoimmune disease with presence of autoantibodies and characteristic multi-organ involvement. Relatives of SLE patients have an increased risk of autoantibody production and autoimmune diseases. Me
Publikováno v:
Lupus. 12:112-116
Thrombotic complications are a significant cause of morbidity and mortality in cancer patients. Studies in Caucasian populations have shown that up to one-third of such patients test positive to antiphospholipid antibodies. Our aim was to determine t
Publikováno v:
Lupus. 23(10)
Vitamin D has important effects on the immune system as it has been shown to exert antiproliferative and relative immunosuppressant effects. Low levels of this hormone may contribute to the immune activation in systemic lupus erythematosus (SLE) and
Autor:
Han Ls, Lin Zhang, Zhangsuo Liu, Hui Li, Yu-Jie He, Guanmin Gao, Xinyou Zhang, Xuejun Zeng, Zhaohui Zheng, Shengyun Liu, Jinyan Guo
Publikováno v:
Lupus. 22(5)
Our objective was to determine metabolic syndrome (MS) prevalence in Chinese patients with systemic lupus erythematosus (SLE) and to investigate the conditions that contribute to its development. 116 patients with SLE classified according to the Amer
Publikováno v:
Lupus. 16(2)
Seventy-two patients with antiphospholipid antibodies (aPL), with or without antiphospholipid syndrome (APS), were studied for detection of heparin-PF4-induced antibodies (HPIA) using a commercial kit (Asserachrom® HPIA) PF4-dependant enzyme-linked
Autor:
A.J. Chamorro, Jordi Yagüe, J C Botero, Miguel Ingelmo, S Segura, Ricard Cervera, Manuel Ramos-Casals, Josep Font, G Salvador, M T Campoamor
Publikováno v:
Lupus. 13(10)
The objective of the study was to analyse the prevalence and clinical significance of hypocomplementemia in a large series of patients diagnosed either with systemic lupus erythematosus (SLE) or with primary antiphospholipid syndrome (APS) and its as
Autor:
Juan Carlos Reverter, Ricard Cervera, F. J. Muñoz-Rodriguez, Josep Font, Gerard Espinosa, Francisco Carmona, Juan Balasch, Dolors Tàssies, Antonio Ordinas, Miguel Ingelmo
Publikováno v:
Lupus. 11(11)
Antiphospholipid antibodies (aPL) may induce acquired activated protein C resistance (acquired APCR). The role of acquired APCR in patients with systemic lupus erythematosus (SLE) is not well known. To evaluate the prevalenceof acquiredAPCR and its a